Probiotic microorganisms: how they affect intestinal pathophysiology.
Heyman
M
M
INSERM EMI 0212, Faculté Necker-Enfants Malades, Paris, France. heyman@necker.fr
Ménard
S
S
D001644:Bifidobacterium / Q000502:physiology; D002648:Child; D003110:Colonic Neoplasms / Q000628:therapy; D004064:Digestive System / Q000378:metabolism / Q000382:microbiology; D004068:Digestive System Physiological Phenomena; D005512:Food Hypersensitivity / Q000628:therapy; D005767:Gastrointestinal Diseases / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D018928:Immunity, Mucosal; D007413:Intestinal Mucosa / Q000276:immunology; D007778:Lactobacillus / Q000502:physiology; D007785:Lactose / Q000378:metabolism; D008954:Models, Biological; D019936:Probiotics / Q000494:pharmacology*
D007785:Lactose